Bài kiểm tra có liên kết hướng dẫn · Trung bình Cấp độ

Câu đố khám phá kháng sinh AI

Kiểm tra quy trình sàng lọc AI, bằng chứng phổ hẹp, tuyên bố tiền lâm sàng so với lâm sàng, sức đề kháng và các thí nghiệm tiếp theo.

Đường dẫn hướng dẫn liên quanKhám phá kháng sinh AI
Câu hỏi 1 của 8

What does the abaucin study establish?

Xem trước mọi câu hỏi8 câu hỏi

Câu trả lời và giải thích xuất hiện khi bạn làm bài kiểm tra.

  1. What does the abaucin study establish?
    • A clinical cure for resistant infections
    • A replacement for susceptibility testing
    • A narrow-spectrum compound with experimental activity against A. baumannii in reported models
    • A broadly effective human antibiotic
  2. What labels trained the discovery model?
    • Bacterial growth-inhibition data from screened molecules
    • Patient survival after treatment
    • Clinician ratings of infection severity
    • Drug prices in a hospital formulary
  3. Why test a predicted antibiotic hit against mammalian cells?
    • To determine its brand name
    • To prove it works in every bacterium
    • To measure how fast the model runs
    • To assess whether activity may reflect harmful nonspecific toxicity
  4. What does a mouse infection model not establish?
    • That researchers can study mechanisms
    • Human safety and clinical efficacy
    • That the compound was tested in an animal
    • That the study included a pathogen
  5. Why examine a strain panel?
    • It replaces mechanism testing
    • It proves resistance cannot emerge
    • Activity against one isolate may not generalize across strains or species
    • Every bacterial strain behaves identically
  6. What should a report include for an antibiotic discovery hit?
    • Only the neural-network architecture
    • Only a predicted score
    • The names of all unrelated compounds
    • Assay, species, strains, controls, selectivity, and evidence stage
  7. What can resistance studies help determine?
    • Whether the model was trained correctly
    • Whether bacteria can evolve reduced susceptibility to the candidate
    • Whether the molecule can be synthesized at scale automatically
    • Whether it treats viral infections
  8. When is it accurate to call an AI-selected compound a treatment?
    • Only after appropriate evidence supports its clinical use
    • As soon as an in-vitro score is high
    • After a model generates a structure
    • When a mouse result is positive